Osteopathic Treatment to Alcohol Withdrawal Syndrome

NCT ID: NCT03916939

Last Updated: 2023-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-26

Study Completion Date

2024-02-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation.

The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions.

Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of osteopathic techniques for facial equilibration decreases the severity of withdrawal symptoms experienced by patients hospitalized in a weekday hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Withdrawal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
simulated osteopathy

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Osteopathy

osteopathic treatment

Group Type EXPERIMENTAL

osteopathy

Intervention Type OTHER

osteopathy treatment

simulated osteopathy

simulated osteopathic treatment

Group Type PLACEBO_COMPARATOR

simulated osteopathy

Intervention Type OTHER

simulated osteopathic sessions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

osteopathy

osteopathy treatment

Intervention Type OTHER

simulated osteopathy

simulated osteopathic sessions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\> 18 years
* Patient hospitalized for a programmed alcohol withdrawal
* Patient not abstinent with alcohol before hospitalization
* Signed informed consent

Exclusion Criteria

* Minor patient
* Patient with an addiction other than alcohol (except tobacco and benzodiazepines)
* Previous participation in the OSTEOOL study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ecole Supérieur d'Ostéopathie

OTHER

Sponsor Role collaborator

Centre Hospitalier Intercommunal Creteil

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chi Creteil

Créteil, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

camille JUNG, MD

Role: CONTACT

01457022268

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Camille BARRAULT, MD

Role: primary

06 62 89 61 27

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OSTEOOL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oxytocin Treatment of Alcohol Dependence
NCT02251912 COMPLETED PHASE2
Oxytocin in Alcohol Use Disorder
NCT02711189 WITHDRAWN PHASE1
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
NCT06173973 ENROLLING_BY_INVITATION PHASE2/PHASE3
Oxytocin Treatment of Alcohol Dependence
NCT02275611 COMPLETED PHASE2
Baclofen for the Treatment of Alcohol Drinkers
NCT01604330 COMPLETED PHASE2/PHASE3
Oxytocin Treatment of Alcohol Withdrawal
NCT01212185 COMPLETED PHASE1